Ohio Public Employees Retirement System (OPERS)’s Vir Biotechnology VIR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.01M Buy
+112,700
New +$898K ﹤0.01% 1314
2025
Q1
Sell
-1,747
Closed -$12.8K 2424
2024
Q4
$12.8K Sell
1,747
-15,733
-90% -$124K ﹤0.01% 2287
2024
Q3
$131K Buy
17,480
+459
+3% +$3.99K ﹤0.01% 1604
2024
Q2
$151K Sell
17,021
-627
-4% -$6.01K ﹤0.01% 1393
2024
Q1
$179K Sell
17,648
-409
-2% -$4.17K ﹤0.01% 1366
2023
Q4
$182K Hold
18,057
﹤0.01% 1388
2023
Q3
$169K Buy
+18,057
New +$258K ﹤0.01% 1384

Other funds holding VIR

Ohio Public Employees Retirement System (OPERS)'s VIR Position: Q1 2026 in Review

Ohio Public Employees Retirement System (OPERS) opened a new position in Vir Biotechnology (VIR) in Q1 2026: 112,700 shares worth $1.01M. The stake represents ﹤0.01% of the portfolio and ranks #1314 among its holdings. This is a return to the name: Ohio Public Employees Retirement System (OPERS) previously reported a position in VIR as recently as Q4 2024.

Ohio Public Employees Retirement System (OPERS) first reported a position in VIR in Q3 2023 and has held it in 7 quarters since. 251 funds tracked by Wall St. Rank hold VIR as of Q1 2026.

  • Ohio Public Employees Retirement System (OPERS) held 112,700 shares of Vir Biotechnology worth $1.01M as of Q1 2026.
  • Vir Biotechnology was a new Ohio Public Employees Retirement System (OPERS) position in Q1 2026.
  • Vir Biotechnology made up ﹤0.01% of Ohio Public Employees Retirement System (OPERS)'s portfolio in Q1 2026, its #1314 holding.
  • Ohio Public Employees Retirement System (OPERS) first reported a position in Vir Biotechnology in Q3 2023 and has held it in 7 quarters since.
  • 251 funds tracked by Wall St. Rank held Vir Biotechnology as of Q1 2026.

Based on Ohio Public Employees Retirement System (OPERS)'s 13F filing for Q1 2026, filed 14 May 2026.